Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial

Wijting, I; Rokx, C; Boucher, C; van Kampen, J; Pas, S; de Vries-Sluijs, T; Schurink, C; Bax, H; Derksen, M; Andrinopoulou, ER; van der Ende, M; van Gorp, E; Nouwen, J; Verbon, A; Bierman, W; Rijnders, B

Rijnders, B (reprint author), Erasmus MC, NL-3000 Rotterdam, Netherlands.

LANCET HIV, 2017; 4 (12): E547

Abstract

Background The high genetic barrier to resistance of dolutegravir might allow for its use as maintenance monotherapy in patients with HIV. We investig......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索